Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2/CPM in Closed Humeral Fractures
NCT00384852Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial of dibotermin alfa in Humerus fracture (4 arms), sponsored by Pfizer. Primary endpoint: Radiographic Fracture Union at 52 weeks. Started Jan 2007; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
Humerus fracture
Beyond the preview
Go deeper on NCT00384852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384852.